Navigation Links
Ratcliff Promotes Jorge Burbano to Senior Associate; Tess Kavanagh and Tony Keung to Associate
Date:6/4/2009

EMERYVILLE, Calif., June 4 /PRNewswire/ -- Ratcliff promoted Jorge Burbano to senior associate and project architects Tess Kavanagh and Tony Y. Keung to associate this month. The award-winning firm (http://www.ratcliffarch.com) provides a broad array of architectural, interior design and planning services to healthcare, academic and civic clients throughout the Western United States.

Jorge Burbano, LEED(R) AP, has more than 20 years of architectural design experience. He is currently guiding the design of several projects, including the master plan site selection for the VA Campus in Livermore, Calif.; the master plan and conceptual design for a new art and music facility and pool/athletic support space for Junipero Serra High School in San Mateo, Calif.; and the implementation of the master plan for Golden Gate University in San Francisco. Burbano has been awarded the American Institute of Architects Alpha Rho Chi Medal. He earned his bachelor's degree in architecture from the Universidad Autonoma de Centro America in 1985 and his master's degree in architecture from the University of New Mexico in 1990.

With more than 13 years of experience, architect Tess Kavanagh is assisting with the design of the Mediated Learning Center at De Anza College in Cupertino, California. She recently completed work on the new Student Services Center for Golden Gate University in San Francisco and assisted with the design of the new medical office building for Kaiser Permanente in Petaluma, California. Prior to joining Ratcliff, Kavanagh was employed by Bechtel and worked on the Dubai International Airport in the United Arab Emirates. She earned her master's degree in architecture from the University of California, Berkeley, and her bachelor's degree in environment
'/>"/>

SOURCE Ratcliff
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ratcliff Designs Hospital of the Future for John Muir Medical Center - Walnut Creek Campus
2. Pathway for Biosimilars Act Protects Patients, Promotes Competition, Preserves Innovation and Creates Quality Jobs, Lilly Says
3. Merrimack Pharmaceuticals Promotes Ulrik B. Nielsen, Ph.D. to Chief Scientific Officer and Edward J. Stewart to Senior Vice President of Business Development
4. BioStorage Technologies, Inc. Promotes Lori Ball to Senior Vice President and Expands Role
5. Genesis HealthCare Promotes Wendy LaBate To Senior Vice President of Operations for the Northeast Area
6. BioMed Realty Trust Promotes Kent Griffin to President
7. AMDL, Inc. Promotes CFO Akio Ariura to Chief Operating Officer and Expands Management Team
8. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
9. China Bionanometer Industries Corporation Promotes New Product Beauty Look in China
10. PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
11. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 22, 2014   Synthetic Biologics, Inc. (NYSE ... for serious infections and diseases, announced today that the ... of Allowance for a composition of matter patent application ... program, SYN-004. This is Synthetic Biologics, first allowed ... and adds to the Company,s extensive C. difficile ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... PureTech , a science and technology development ... today the closing of a $55 million growth ... a $120 Billion group of funds. The funding ... forward and to advance new healthcare related products ... really go for the big ideas that can ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
... Northwest,Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; ... today that Lonza Group AG has,withdrawn all ... and other NWBT DCVax(R) products other than ... vaccine products infringed,certain gene expression technology patents ...
... offers substance abuse treatment for teens and adults, ... has announced the expansion of its treatment services to,include ... 12 - 17 as well,as adults, and the hospital ... health and dual diagnosis (substance abuse and,mental illness)., ...
... ALTO, Calif., Dec. 19 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... Barron, MD, FACC to its Board of Directors. Dr. ... Officer at Genentech,where he leads the Development organization, which ... Barron joined Genentech in 1996 as a clinical scientist ...
Cached Biology Technology:Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics 2Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics 3Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics 4Highlands Behavioral Health Hospital Unveils New Substance Abuse Detox Program 2Alexza Elects Dr. Hal V. Barron to Its Board of Directors 2Alexza Elects Dr. Hal V. Barron to Its Board of Directors 3
(Date:10/16/2014)... constantly wages war on the human body. Battles ... stalemate. In pancreatic cancer, this stalemate—known as tumor ... aggressively malignant, a phenomena that is poorly understood. ... the laboratory of Salvatore Torquato, a Professor of ... conditions surrounding tumor dormancy and the switch to ...
(Date:10/16/2014)... researchers have challenged conventional thinking on how the bowel ... mechanism for how bowel cancer starts. , The researchers ... and regenerating the ,crypts, that are a feature of ... involved in bowel cancer development, a controversial finding as ... , Using 3D imaging technologies, Dr Chin Wee Tan ...
(Date:10/16/2014)... 16, 2014) – Post-menopausal women experienced improvements in ... levels or genital bleeding, after 12 weeks of ... fermented soy germ-based nutritional supplement previously shown to ... new peer-reviewed pilot study reported in a poster ... scientific meeting. , "These data documented improved ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Cryptic clues drive new theory of bowel cancer development 2S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2
... By manipulating highly specific gene-regulating molecules called microRNAs, scientists at ... in singling out and repressing stem-like cells in mouse breast ... to cancer. If certain forms of breast cancer do ... believe to be the case, then it is critical to ...
... induce cells to form parallel tube-like structures that could one ... found that they can control the cells, development by growing ... the work was posted this month in an online issue ... day be transplanted into tissues such as the kidneys, liver, ...
... events that are critical to a healthy life, giving ... to think. But thats if the neurotransmitters are getting ... cells, neurons or other cells. Now a ... transcription factor that controls a neurotransmitter in the nematode ...
Cached Biology News:CSHL scientists identify and repress breast cancer stem cells in mouse tissue 2CSHL scientists identify and repress breast cancer stem cells in mouse tissue 3MIT works toward engineered blood vessels 2Overexcited neurons not good for cell health 2Overexcited neurons not good for cell health 3
Human Xg Affinity Purified Polyclonal Ab Keywords: Xg glycoprotein, hereditary hemorrhagic telangiectasia Protein Family: ...
nuclear RNA export factor 1, mRNA...
Mycoplasma tested...
Human PDGF, CF...
Biology Products: